Cortical lesions constitute an important part of multiple sclerosis pathology. Although inflammation appears to play a role in their formation, the mechanisms leading to demyelination and neurodegeneration are poorly understood. We aimed to identify some of these mechanisms by combining gene expression studies with neuropathological analysis. In our study, we showed that the combination of inflammation, plaque-like primary demyelination and neurodegeneration in the cortex is specific for multiple sclerosis and is not seen in other chronic inflammatory diseases mediated by CD8-positive T cells (Rasmussen's encephalitis), B cells (B cell lymphoma) or complex chronic inflammation (tuberculous meningitis, luetic meningitis or chronic purulent meningitis). In addition, we performed genome-wide microarray analysis comparing micro-dissected active cortical multiple sclerosis lesions with those of tuberculous meningitis (inflammatory control), Alzheimer's disease (neurodegenerative control) and with cortices of age-matched controls. More than 80% of the identified multiple sclerosis-specific genes were related to T cell-mediated inflammation, microglia activation, oxidative injury, DNA damage and repair, remyelination and regenerative processes. Finally, we confirmed by immunohistochemistry that oxidative damage in cortical multiple sclerosis lesions is associated with oligodendrocyte and neuronal injury, the latter also affecting axons and dendrites. Our study provides new insights into the complex mechanisms of neurodegeneration and regeneration in the cortex of patients with multiple sclerosis.
Introduction
Multiple sclerosis is traditionally seen as a disease that affects the white matter giving rise to focal inflammatory demyelinating lesions . Recent studies on the pathology of multiple sclerosis, however, challenged this concept by providing evidence for extensive grey matter lesions in the cerebral (Peterson et al., 2001; Bo et al., 2003; Kutzelnigg et al., 2005) and cerebellar cortex (Kutzelnigg et al., 2007) and in the hippocampus (Geurts et al., 2007) . Despite the primary demyelinating nature of cortical lesions, profound degeneration also affects cortical neurons, axons and synapses (Peterson et al., 2001; Wegner et al., 2006; Dutta and Trapp, 2011) .
Cortical lesions arising during early (Lucchinetti et al., 2011) and late (Kutzelnigg et al., 2005; Howell et al., 2011) disease stages are associated with inflammation. In lesions developing in the progressive stage, the degree of meningeal inflammation correlates with the extent of active demyelination and neurodegeneration Choi et al., 2012) . Thus, inflammation may drive cortical lesions, but it remains unresolved, whether cortical primary demyelination is a multiple sclerosis-specific event, which types of inflammatory cells are involved and which molecular mechanisms evoke tissue injury. In this study, we compared cortical pathology in multiple sclerosis with that seen in a large spectrum of other inflammatory and neurodegenerative brain diseases and found that the combination of inflammation, plaque-like primary demyelination and neurodegeneration is specific for multiple sclerosis. The second part of the study focused on global gene expression studies analysing potential molecular pathways of tissue injury in active cortical multiple sclerosis lesions. The latter were defined by the presence of macrophages containing degradation products reactive for myelin or neuronal antigens. Since the data suggested oxidative injury, DNA damage, and apoptosis as potential mechanisms of tissue degeneration, we analysed the expression of proteins involved in oxidative burst as well as the presence of oxidized lipids and DNA fragmentation in a broad sample of cortical multiple sclerosis lesions in comparison with the normal and diseased controls using immunohistochemistry and terminal deoxynucleotidyl transferase dUTP nick end labelling (TUNEL) staining.
Materials and methods

Sample characterization
Archival formaldehyde-fixed and paraffin-embedded (FFPE) autopsy material collected in the archives of the Centre for Brain Research and the Institute of Neurology were used (Table 1) . The study was approved by the Ethical Committee of the Medical University of Vienna (EK. No. 535/2004 and 087/01/2012) . It included 21 cases of multiple sclerosis comprising acute multiple sclerosis (n = 6), relapsing-remitting multiple sclerosis (n = 1), secondary progressive multiple sclerosis (n = 7) and primary progressive multiple sclerosis (n = 7). As controls, cases of chronic tuberculous meningitis (n = 4), luetic meningitis (n = 1), chronic purulent meningitis (n = 1), Rasmussen's encephalitis (n = 5), B cell lymphomas affecting meninges and cortex (including one EBV + lymphoma; n = 4), Alzheimer's disease (n = 11) and age-matched controls without any detectable brain disease (control subjects; n = 17) were included. For basic neuropathology of each case, multiple tissue blocks from all brain regions were stained with haematoxylin/eosin, Luxol Fast blue myelin stain and Bielschowsky silver impregnation. The selection of tissue blocks taken for microarray and neuropathological analysis depended on the clinical diagnosis of each patient (Table 1) . For microarray analysis we selected frontal association cortex for multiple sclerosis and controls, frontobasal (TB1 and TB2) and temporobasal (TB3) cortex for tuberculous meningitis and temporal cortex for Alzheimer's disease. For neuropathological studies the blocks (between three and eight) from patients with Alzheimer's disease or tuberculous meningitis included cortical areas (frontal, temporal, parietal and occipital), while in case of B cell lymphoma between one and three blocks were chosen, which contained infiltration of neoplastic B cells in meninges or cortex (frontal and parietal). Tissue samples from patients with Rasmussen's encephalitis derived from temporal cortico/subcortical neurosurgical resections and were, thus, restricted to one block per case. For control cases, basic neuropathology was performed on eight to 15 tissue blocks from all brain regions to exclude confounding pathology. From those three to six blocks comprising frontal, parietal, and temporal cortex were selected for further analysis. In multiple sclerosis cases, cortical lesions were either identified by analysis of multiple tissue blocks (n = 10 cases) or were specifically trimmed from hemispheric or double hemispheric sections (n = 11 cases). The architecture of active cortical lesions was complex. In general, they contained a fully demyelinated area, which was surrounded by an area of variable size with reduced myelin density and profound microglia activation, located between the demyelinated lesion and the normal appearing grey matter. However, microglia activation alone was not sufficient for the identification of an active lesion, since a rim of activated (iron containing) microglia can be seen in multiple sclerosis lesions, which do not expand in the subsequent years (Bian et al., 2012) . Thus, we used the presence of degradation products in macrophages reactive for myelin or neuronal antigens, such as neurofilament, as an additional marker for active cortical lesions ( Fig. 1 and Supplementary  Fig. 1 ). For the investigation of molecular mechanisms of tissue injury by microarray analysis, we selected subpial cortical lesions with a zone of perilesional activity as defined above.
Immunohistochemistry
Consecutive 5 -mm thick serial sections were cut, routinely deparaffinized and endogenous peroxidase was blocked with H 2 O 2 /methanol. Non-specific antibody binding was blocked by incubating the section in 10% foetal calf serum. Antigen retrieval procedures and primary antibodies used for immunohistochemistry are listed in Table 2 . Primary antibodies were applied overnight at 4 C. For immunohistochemical controls, either primary antibodies were omitted or unrelated sera or monoclonal antibodies of the same immunoglobulin class were used. Antibody binding was routinely visualized using 3,3'-diaminobenzidine, which was occasionally enhanced by biotinylated tyramine amplification (King et al., 1997) . Alternatively, Fast blue B salt or 3-amino-9-ethylcarbazole were used for signal development. Before mounting of sections, cell nuclei were counterstained with haematoxylin. Confocal fluorescence immunohistochemistry was performed on paraffin sections as described for light microscopy with some modifications. For fluorescent double labelling with primary antibodies from different species (mouse-anti-E06 and goat-anti-carbonic anhydrase II, rabbit-anti-GFAP, rabbit-anti-neurofilament or rabbit-anti-calbindin, respectively), antibodies were applied simultaneously at 4 C overnight.
After washing, secondary antibodies (biotin-conjugated donkey-antirabbit, 1:200; Cy3-conjugated donkey-anti-goat, 1:200; Cy2-conjugated donkey-anti-mouse, 1:200; all antibodies from Jackson ImmunoResearch) were applied simultaneously for 1 h at room temperature. This procedure was followed by application of streptavidinCy5 (Jackson ImmunoResearch; 1:75) for 1 h at room temperature. Finally, fluorescent preparations were embedded and examined using a confocal laser scan microscope (Leica SP5) equipped with lasers for 488, 543 and 633 nm excitation. Scanning for Cy2 (488 nm), Cy3 (543 nm) and Cy5 (633 nm) was done sequentially to rule out fluorescence bleed through.
TUNEL staining for DNA damage TUNEL staining was performed essentially as described previously (Gold et al., 1993) and has already successfully been applied previously for analysis of DNA fragmentation in Alzheimer's disease and controls (Lassmann et al., 1995) . In the present study we used the In Situ Cell Death Detection Kit (Roche). total number of counted cortical neurons. To examine the extent of demyelination, proteolipid protein (PLP)-stained slides were scanned and the extent of demyelination was calculated as demyelinated area in relation to total cortex area.
Quantification of immunohistochemistry and TUNEL staining
RNA extraction and microarrays
For gene expression studies, three active multiple sclerosis lesions (the fulminate active lesion of Case MS1 and two chronic active lesions from Cases MS2 and MS3), three cortex samples from patients with tuberculous meningitis, three Alzheimer's disease cases, and three controls without brain pathology were selected ( Table 1) . As archival formaldehyde-fixed and paraffin-embedded autopsy material with unknown time spans and storage conditions between sampling and fixation was used, RNA preservation of more than 150 multiple sclerosis tissue blocks and 40 tissue blocks containing control material (Alzheimer's disease, tuberculous meningitis, control subjects), was assessed by in situ hybridization for PLP as described (Breitschopf et al., 1992) . Tissue blocks with strong and specific in situ hybridization signals in oligodendrocytes after short development time (510 h) were selected for further studies. Ten to 20 6-10 -mm thick sections were cut under RNase-free conditions. Cortical tissue blocks for microarray analysis were selected according to the presence of lesions typical for the different disease entities. Cortical areas including all cortical layers from Alzheimer's disease, tuberculous meningitis and control subjects were micro-dissected. In tuberculous meningitis cases, these cortical areas were further restricted to sites with profound meningeal and parenchymal inflammation. For multiple sclerosis cases, we microdissected cortical areas with subpial demyelination of at least the outer four cortical layers. These lesions contained a broad zone around the plaque with profound microglia activation and the presence of macrophages with degradation products reactive for myelin or neuronal antigens. Thus, for messenger RNA analysis, these multiple sclerosis blocks also contained all cortical layers and, dependent on the degree of activity, a zone of variable size with signs of active tissue injury. Isolation, amplification, and quality assessment of messenger RNA were done as extensively described before . Briefly, total RNA was isolated using the High Pure FFPE RNA Micro Kit (Roche) according to the manufacturer's instructions. The concentration of isolated total RNA was too low for any RNA integrity measurements. Instead, messenger RNA was amplified using poly(T) primers and the Arcturus Õ Paradise Õ FFPE Amplification Kit (Applied Biosystems, Life Technology). After the first round of in vitro transcription, the quality of the samples was tested. Owing to RNA fragmentation and cross-linking during formaldehyde fixation, it is almost impossible to isolate full length RNA from formaldehyde-fixed and paraffin-embedded tissue. Therefore, routine endpoint PCR for the housekeeping gene actin, beta (ACTB) was performed to verify that RNA fragments were sufficiently long to use them as probes for microarrays. Primers were designed in such a way that the forward primer binds 472 bases upstream of the poly(A) tail. Endpoint PCR was run with the following settings: forward: 5'-TTGACTCAGGATTTAAAA ACTGG-3', reverse: 5'-AGGGACTTCCTGTAACAACGC-3'; 10 min denaturation; followed by 40 cycles of denaturation (30 s, 95 C), annealing (30 s, 55 C), and extension (30 s, 72 C). Only when a sufficient amount of PCR product was found, the samples qualified for a second round of in vitro amplification. The resulting antisense RNA was sent out for hybridization to Agilent-014850 Whole-Human Genome Microarrays 4x44K (G4112F). RNA labelling, microarray hybridization and scanning, as well as quantile normalization of raw data were carried out externally (Source BioScience imaGenes GmbH). For data analysis, two different approaches were used. On the one hand, all genes significantly changed (P 5 0.01; Student's t-test) in cases with multiple sclerosis (Cases MS1-3) in comparison with other cases (Alzheimer's disease, tuberculous meningitis and control subjects) were evaluated. On the other hand, to have the ability to assess the inflammatory component of the fulminate lesion of Case MS1, all massively up-or down regulated genes (log 2 fold-changes 44 or 5 À4.5, respectively) in Case MS1 in comparison with all other cases (other multiple sclerosis, Alzheimer's disease, tuberculous meningitis and control subjects) were examined. As significance testing was not possible for this analysis approach, restrictive cut-offs were used instead. They were based on the observation that above and below a log 2 fold-change of 4 and 4.5, respectively, the detected differences were granted to be exclusively present in Case MS1, whereas the gene expression values in all other cases (tuberculous meningitis, Alzheimer's disease and control subjects) were low. Functions of the multiple sclerosis-specific genes were determined based on several sources: There are numerous amyloid plaques in the cortex (V; IHC for Aß peptide), but the architecture of cortical myelin is preserved (U; IHC for PLP). Only in the centre of amyloid plaques (W; IHC for Aß), there is a minor loss of myelin (X; IHC for PLP). MS = multiple sclerosis; TB = tuberculous meningitis; RE = Rasmussen's encephalitis; BLY = B cell lymphoma; AD = Alzheimer's disease; *subpial myelin band. Scale bar = 100 mm for A-D, F-H, J-O, R, S and U-X; Scale bar = 50 mm for E, I, P, Q and T.
pantherdb.org), and KEGG Kyoto Encyclopaedia of Genes and Genomes (http://www.genome.jp/kegg). Particularly, PubMed was screened for genes with known functions in multiple sclerosis or experimental autoimmune encephalomyelitis. Based on the microarray data (deposited in NCBI's Gene Expression Omnibus; GEO Accession Number GSE32645), genes related to inflammation, structural changes, or oxidative injury were selected and immunohistochemistry was performed on serial sections immediately adjacent to the sections used for gene expression profiling. For these exemplary genes, it could be shown that protein expression visualized by immunohistochemistry followed the up-and down regulation trends of the microarray data ( Supplementary Fig. 1 ). Furthermore, TaqMan Õ real-time PCR was performed to validate selected multiple sclerosis-specific genes (Supplementary Table 4 ).
Statistical analysis
Descriptive analysis included median value and range, percentages, scatter plots and box plots. For comparisons of multiple groups, the Kruskal-Wallis test was used, followed by pair-wise Mann-Whitney U-tests and Bonferroni-Holm correction. For the analysis of microarray data (Cases MS1-3 in comparison with all other cases pooled in one group), Student's t-tests were performed. The reported P-values are results of two-sided tests. A P-value 40.05 was considered statistically significant. Analyses were done using PASW Statistics 18 (SPSS Inc.).
Results
Focal lesions of primary demyelination are specific for multiple sclerosis
In a first step, we analysed demyelination and neurodegeneration in the cortex of patients with multiple sclerosis in comparison with other inflammatory and neurodegenerative diseases. In multiple sclerosis, cortical pathology was characterized by the presence of large plaques of primary demyelination (complete loss of myelin with axonal preservation such as preservation of phosphorylated neurofilament-reactive profiles) as described previously (Peterson et al., 2001; Kutzelnigg et al., 2005) . In one case of secondary progressive multiple sclerosis (Case MS1), fulminate inflammatory cortical lesions were present, similar to those described in early multiple sclerosis (Lucchinetti et al., 2011) with profound inflammation in the meninges (Fig. 1B) , abundant perivascular inflammatory cuffs ( Fig. 1D and Supplementary Fig. 1 ) and T and B lymphocyte infiltration into the cortical parenchyma ( Fig. 1C and Supplementary Table 1 ). Active cortical demyelination (Fig. 1A) was reflected by the presence of activated macrophages containing myelin degradation products reactive for PLP (Fig. 1E) . The other multiple sclerosis cases (shown representatively by Case MS2 in Fig. 1F-I ) exhibited cortical demyelinated lesions as described . In these expanding cortical lesions, lymphocyte infiltration was restricted to the meninges and the zones of lesional activity. A variable degree of microglia activation was observed, forming a band of high cell density at the margin towards the normal appearing grey matter (see Supplementary  Fig. 1 ). In these areas, few diffusely dispersed T cells were present ( Fig. 1H ) and microglia cells contained myelin degradation products.
Cortical lesions in patients with tuberculous or luetic meningitis also showed strong meningeal and parenchymal inflammation with a similar cellular composition of T cells, B cells, plasma cells, and macrophages as in multiple sclerosis (Fig. 1K-M) . In some cases, the infiltrates additionally contained granulocytes. Despite the massive inflammatory reaction in the cortex, no focal primary plaque-like demyelination was present (Fig. 1J) .
Cortical lesions from patients with Rasmussen's encephalitis (a paradigmatic example of encephalitis mediated by MHC class I restricted T cells) showed only minor meningeal inflammation, dominated by T cells and macrophages, but profound diffuse T cell infiltration of the cortical parenchyma (Fig. 1P) . These infiltrates were associated with massive microglia activation and neuronal and astrocytic degeneration (Fig. 1O) (Bien et al., 2002; Bauer et al., 2007) . Again, no indication for focal multiple sclerosis-like primary demyelination was found ( Fig. 1N and Q) .
In B cell lymphomas affecting the cortex, massive infiltration of the meninges and the cortical parenchyma by neoplastic B cells (Fig. 1S) and a variable extent of T cell infiltration and microglia activation were seen. In severely affected regions, this resulted in displacement of the cortical parenchyma by neoplastic cells. In areas of very dense B cell infiltration, myelin was pushed aside by aggregated B lymphocytes (Fig. 1T) , but there was no indication of primary demyelination (Fig. 1R) .
No plaque-like demyelination was present in the cortex of patients with Alzheimer's disease (Fig. 1U) . However, immunohistochemistry for proteolipid protein revealed a minor loss of myelin within the core and the vicinity of amyloid plaques (Fig. 1V-X ) (Mitew et al., 2010) .
These data indicate that the formation of plaque-like primary demyelinating cortical lesions is multiple sclerosis-specific and does not simply reflect tissue damage induced by inflammatory mechanisms or mediators.
Comparative analysis of gene expression in cortical lesions
Quantitative immunohistochemistry (Table 3 ) of disease and control cases selected for our microarray study confirmed that inflammation mediated by T cells, B cells, and microglia activation were most pronounced in tuberculous meningitis, whereas demyelination and oligodendrocyte loss were restricted to multiple sclerosis lesions. Neuronal and axonal injury was present in multiple sclerosis, tuberculous meningitis, and Alzheimer's disease, but was highest in multiple sclerosis compared with the other diseases.
Analysing our microarray data, we found 109 genes significantly up-or downregulated in multiple sclerosis in comparison with all other disease and control cases (P 5 0.01; Supplementary Table 2 ). In a separate approach, we examined gene expression in Case MS1, which presented with fulminate inflammatory cortical demyelination. Comparing this single multiple sclerosis case with all other cases included in our gene expression study allowed us to specifically examine the inflammatory component of this active cortical lesion. As a restrictive cut-off point we chose genes that were differentially up-(44-fold log 2 ) or downregulated (5À 4.5-fold log 2 ) compared with all other cases, including tuberculous meningitis cases showing the highest extent of inflammation. This resulted in 192 hits (144 upregulated and 48 downregulated; Supplementary Table 3) . Taking together the two analysis approaches, we identified 301 multiple sclerosis-specific genes. Among those genes, 82% could be grouped into three major categories (Fig. 2 and Supplementary Tables 2 and 3): inflammation and immune cell activation/migration (24%), oxidative injury, DNA damage/repair, and cell death (28%), and tissue repair/regeneration (52%). Assignment of genes to multiple categories was tolerated. A comprehensive tabular summary of all multiple sclerosis-specific genes including log 2 fold-changes, Pvalues, gene accessions and gene functions, can be found in Supplementary Tables 2 and 3.
Category 1: genes associated with inflammation
Differential expression of inflammation-associated genes was mainly seen in the highly inflammatory cortical lesions of Case MS1 (Supplementary Table 3 ). Functional grouping revealed that many of the identified genes code for proteins involved in antigen recognition of class I and class II restricted T cells and in the regulation of Th1 and Th17 T-cell responses (10 genes), in microglia and macrophage function (seven genes), and in chemokine/cytokine signalling and leucocyte recruitment (18 genes). Profound multiple sclerosis-specific changes were also seen for genes involved in synthesis and function of selectins.
Category 2: genes associated with cell death, DNA damage and DNA repair
The most prominent changes in gene expression (Fig. 2, Table 4,  Supplementary Tables 2 and 3) were found for genes involved in different steps of apoptosis, DNA damage, p53 function and DNA repair (Table 4) . They also included potassium and chloride channels controlling cell volume in the course of cell body or cell process degeneration, or genes involved in the modulation of excitotoxic or ischaemic cell death. This was in line with the identification of another cluster of genes with multiple sclerosis-specific expression, which was related to hypoxia, oxidative stress and mitochondria (Table 4) .
Category 3: reaction to tissue injury and association with tissue repair
This category constituted the largest one (Fig. 2, Table 5, Supplementary Tables 2 and 3 ). A major subgroup included genes coding for proteins involved in RNA metabolism or regulation of transcription or translation. Another considerable cluster was related to development in general and to brain development in particular. It comprised genes necessary for various cellular functions such as cell survival, growth, and differentiation or control of cytoskeletal components (in particular tubulin turnover). One further group contained genes functionally associated with axonal and synaptic biology and regeneration (Table 5 ). The majority of these were either involved in axonal growth and guidance, or in synapse function. As expected, we also found significantly increased expression of some myelin-and oligodendrocyte-related genes in multiple sclerosis. Their expression was highest in Cases MS2 and MS3, which contained demyelinated and remyelinating lesion centres with rims of active demyelination at the border to the white matter. Increased oxidative damage and DNA strand breaks in cortical multiple sclerosis lesions compared with tuberculous meningitis and other controls
So far, our microarray data suggested multiple sclerosis-specific changes in the expression of genes related to oxidative injury and DNA damage in cortical lesions. We therefore attempted to confirm these data in the entire sample or cases with multiple sclerosis listed in Table 1 . From the individual cases with multiple sclerosis, cortical lesions were selected, which contained a demyelinated area with oligodendrocyte loss, surrounded by an area of microglia activation with interspersed macrophages containing early tissue degradation products and an adjacent area of normal appearing grey matter. In comparison with control cortices, a significant loss of neurons (31.1% loss; P 5 0.01) was seen in the demyelinated areas of multiple sclerosis cortex, which is in the range of that described previously (Vercellino et al., 2005; Wegner Genes of both microarray analysis approaches are included. For Comparison 1 [significantly (P 5 0.01) changed genes in Cases MS1-3 in comparison with all other cases (TB1-3, AD1-3, and CO1-3; n = 9)], log 2 fold-changes as well as the corresponding P-values are shown. For Comparison 2 [massively up-or downregulated genes (log 2 fold-changes 44 or 5À4.5, respectively) in MS1 in comparison with all other cases], only the log 2 -transformed fold-changes are given. A complete gene list is provided in Supplementary Tables 2 and 3. et al. Magliozzi et al., 2010; Choi et al., 2012) and in the cortices of Alzheimer's disease (40%; P 5 0.001; Supplementary  Fig. 2 ). Our previous studies of active white matter lesions (Haider et al., 2011; Fischer et al., 2012) indicated that immunohistochemistry for oxidized phospholipids (E06 immunoreactivity) is a sensitive marker for degenerating oligodendrocytes and dystrophic axons. In cortical multiple sclerosis lesions, we observed a similar immunoreactivity for oxidized phospholipids in the mentioned cell types, concentrated at sites of ongoing demyelination (Fig. 3A and M). Neurons with intense cytoplasmic accumulation of oxidized phospholipids (Fig. 3N) were significantly more abundant in active cortical multiple sclerosis lesions than in lesions of tuberculous meningitis, luetic meningitis, chronic purulent meningitis (P 5 0.05), Alzheimer's disease (P 5 0.05) or controls (P 5 0.001; Figs 3A-D and 4A ). In addition, oxidatively damaged neurons showed process fragmentation ( Fig. 3E -H, O and P) or nuclear changes of necrosis-or apoptosis-like cell death as defined earlier (Muller et al., 2004) (Fig. 3I and J) . Furthermore, nerve cells exhibiting central chromatolysis, a sign of proximal axon transection, also showed profound E06 immunoreactivity ( Fig. 3K and L) . Additionally, we performed TUNEL staining for DNA strand breaks. TUNEL-positive nuclei of neurons and oligodendrocytes were most frequently seen in multiple sclerosis lesions in the areas of active demyelination and tissue injury (Fig. 3R) , whereas their number was much smaller in the demyelinated lesion centre and the normal appearing grey matter (Fig. 4B) . Few TUNEL-positive nuclei were seen in the cortex of controls or patients with tuberculous meningitis (Figs 3S and 4B ). Double staining for TUNEL and oxidized phospholipids showed that neurons with oxidative damage either contained condensed nuclei with high TUNEL reactivity, suggestive for apoptosis (Fig. 3U ), or nuclei with small focal spots of damaged DNA (Fig. 3T) . Immunohistochemistry for activated caspase 3 was negative throughout the whole tissue sample, suggesting caspase-independent cell death (data not shown). Apoptosis inducing factor was present in the mitochondria of healthy neurons in control and multiple sclerosis tissue (Fig 3V) . In active multiple sclerosis lesions, however, neurons were seen, which in addition to mitochondrially located apoptosis inducing factor also showed diffuse apoptosis inducing factor immunoreactivity in the cytoplasm and presence of apoptosis inducing factor in cell nuclei (Fig. 3W) . Cells with cytoplasmic accumulation of oxidized phospholipids were mainly present in cortical areas with high density of activated microglia expressing the NADPH oxidase component p22phox (Fig. 5A) . Processes of p22phox-positive microglia were attached either to the cell body (Fig. 5B) or to dendrites of neurons with oxidative injury (Fig. 5C ). Immunohistochemistry for inducible nitric oxide synthase (iNOS) revealed that active cortical multiple sclerosis lesions contain only few inducible nitric oxide synthasereactive cell bodies or processes of microglia (Fig. 5D) . Macrophages with high inducible nitric oxide synthase immunoreactivity were seen in more advanced white matter lesions (Fig. 5E ). These findings are in line with our microarray results showing an up-regulation of certain NADPH oxidase subunits (mainly components of NOX1 and NOX2 complexes) in cortical multiple sclerosis lesions in comparison with tuberculous meningitis or control cases (Fig. 5F ).
Discussion
Active cortical demyelination and neurodegeneration in multiple sclerosis are associated with inflammation in the cortical tissue itself (Lucchinetti et al., 2011) or in the meninges (Kutzelnigg et al., 2005; Howell et al., 2011) . It has thus been suggested that tissue injury is either mediated by inflammatory cells or their soluble mediators diffusing into the cortex and inducing tissue damage either directly or indirectly through microglia activation . Several types of inflammatory cells, including T cells or B cells, are regarded as particularly important in multiple sclerosis pathogenesis and thought to trigger demyelination and neurodegeneration in a non-specific 'bystander' fashion (Wisniewski and Bloom, 1975) . A previous study (Moll et al., 2008) indicated that cortical demyelination may be multiple sclerosis-specific, but this conclusion was based on diseases with inflammatory reactions quite different from multiple sclerosis. In our study, we confirm this view by focusing on diseases, which to our knowledge more closely reflect key inflammatory components operating in multiple sclerosis lesions. Thus, demyelination and neurodegeneration in multiple sclerosis are not unspecific consequences of inflammation, but appear to involve multiple sclerosisspecific mechanisms of tissue injury.
Microarray studies have been performed on cortical tissue of multiple sclerosis before. They revealed changes related to mitochondrial function in the non-demyelinated motor cortex (Dutta et al., 2006) , to axonal transport and synaptic function , to the regulation of oligodendrocyte differentiation (Schmidt et al., 2012) and to intrathecal immunoglobulin synthesis (Torkildsen et al., 2010) . In contrast to our current study, they focused on normal appearing grey matter or demyelinated areas, but not on areas of active demyelination and tissue injury. Furthermore, they did not include other disease controls. Thus, the prominent expression of immunoglobulin related genes described by Torkildsen et al., (2010) did not appear in our results, because tuberculous meningitis, similar to multiple sclerosis, shows profound intrathecal immunoglobulin synthesis.
Our results showed multiple sclerosis-specific gene expression changes in mainly three different molecular pathways: inflammation, oxidative stress associated with DNA damage, and regenerative mechanisms affecting oligodendrocytes, neurons and neuronal cell processes.
Multiple sclerosis-specific gene expression related to inflammation (Supplementary Tables 2 and 3 ) involved molecules important for antigen presentation and polarization of MHC class I and II restricted T cells towards Th1 and Th17 pathways (Tzartos et al., 2008) or macrophage/microglia activation. Downregulation of the expression of the co-stimulatory molecule CTLA4 in active cortical lesions (Supplementary Table 3 ) is in agreement with the proposed anti-inflammatory function of this molecule in patients with multiple sclerosis (Joller et al., 2012) . Results supporting our current data have been reported before in other gene expression studies (Whitney et al., 1999; Lock et al., 2002; Mycko et al., 2003) and interpretation of the data is in agreement with inflammatory pathways identified in genome-wide association studies on multiple sclerosis susceptibility (Sawcer et al., 2011) . Our study further (Muller et al., 2004) in neurons with extensive accumulation of oxidized phospholipids. Neurons with numerous fine speckles of condensed chromatin resembling identified a number of molecules that are instrumental in leucocyte trafficking into inflammatory lesions including integrin alpha 9, a binding partner of vascular cell adhesion molecule (VCAM). Blockade of VCAM/integrin interaction is currently a very effective anti-inflammatory treatment in patients with multiple sclerosis (Polman et al., 2006) . Our results also indicate that selectins, which mediate inflammation in peripheral organs and the brain through integrin activation (Prendergast and Anderton, 2009; Alvarez et al., 2011; Zarbock et al., 2012) , may play a role in regulating leucocyte trafficking in cortical multiple sclerosis lesions in the progressive stage of the disease. High expression of some selectins has also been shown before in microarray studies on microdissected blood vessels from patients with multiple sclerosis (Cunnea et al., 2010) .
Regarding mechanisms of tissue injury, which were in the main focus of our study, our results suggest that oxidative damage plays a major role in the processes of cortical oligodendrocyte degeneration, demyelination and neuronal damage. These resemble mechanisms observed previously in active white matter lesions and adjacent normal appearing white matter. Expression of enzymes involved in oxygen (Gray et al., 2008; Fischer et al., 2012) and nitric oxide radical production (Liu et al., 2001; Marik et al., 2007; Zeis et al., 2009) , the abundance of oxidized lipids and DNA in degenerating oligodendrocytes and axons (Haider et al., 2011) , the increased expression of molecules involved in antioxidant defence (van Horssen et al., 2008) and the presence of hypoxia-like tissue injury in active lesions and the adjacent normal appearing white matter (Aboul-Enein et al., 2003; Graumann et al., 2003; Trapp and Stys, 2009 ) have been shown before. Oxidative stress is assumed to lead to mitochondrial injury in multiple sclerosis lesions (Dutta et al., 2006; Mahad et al., 2008; Campbell et al., 2011; Lassmann et al., 2012) . Here we show that immunoreactivity for oxidized phospholipids is much higher in neurons of active cortical multiple sclerosis lesions than in all other conditions studied (tuberculous meningitis, Alzheimer's disease, and control subjects). Furthermore, the expression of genes involved in DNA damage and repair was highly up-regulated in multiple sclerosis lesions in comparison with other inflammatory or neurodegenerative controls such as tuberculous meningitis or Alzheimer's disease (Table 4, Supplementary Tables 2 and 3 ). This was also confirmed by the much higher incidence of cells with TUNEL reactivity in areas of active demyelination and tissue injury. TUNEL reactivity, which has been shown before to occur in low incidence in inactive cortical multiple sclerosis lesions (Peterson et al., 2001) , may reflect apoptotic cell death, but also reversible DNA injury. In line with previous studies, apoptosis in multiple sclerosis lesions was not associated with caspase 3 activation (Barnett and Prineas, 2004) , but with the liberation of apoptosis inducing factor from mitochondria and its nuclear translocation (Veto et al., 2010) . Neuronal cell death within active lesion areas may at least in part be responsible for neuronal loss in established lesions.
The mechanisms that drive oxidative injury and neurodegeneration in multiple sclerosis lesions are currently not fully understood. Persistent inflammation in meninges and cortical parenchyma appears to be one important driving force Choi et al., 2012; Lucchinetti et al., 2011) . In addition, factors related to ageing and to chronicity of the disease may play a role. As an example, age-related iron accumulation in the human brain may amplify oxidative injury (Lassmann et al., 2012) . Furthermore, it was shown in a recent study that the topography of cortical lesions may be related to distant lesions within the white or deep grey matter (Kolasinski et al., 2012) , indicating a role of anterograde or retrograde degeneration in the precipitation of cortical lesions. This may also in part explain the differences between cortical lesions in multiple sclerosis and tuberculous meningitis, the latter exposing the cortex to inflammation in the absence of pre-existing distant neurodegeneration.
An interesting observation of our study is that oxidative injury of neurons in the multiple sclerosis cortex coincides with beading and fragmentation of axons and dendrites. Degeneration of neuronal processes was present in cells, in which the peri-nuclear cell body remained morphologically intact. This is further supported by our microarray analyses comprising many genes related to axonal, dendritic, and synaptic regeneration. A similar result has been obtained in previous work analysing gene expression in hippocampal multiple sclerosis lesions , and it was suggested that the profound axonal injury in cortical multiple sclerosis lesions is related to increased vulnerability of demyelinated axons . Our study proposes an additional mechanism: direct oxidative injury and focal damage of axons and dendrites due to the primary destructive events. Partial repair of neuronal cell processes in cortical multiple sclerosis lesions may occur in parallel with remyelination (Albert et al., 2007) and may be associated with functional plasticity seen in MRI studies (Rocca and Filippi, 2007; Caramia et al., 2010) .
We are aware that our study has limitations regarding the analysis of whole-genome microarrays. RNA was isolated from formaldehyde-fixed and paraffin-embedded material, which is known to be inferior in comparison with fresh frozen tissue. Eisele et al. (2012) published a comprehensive study comparing formaldehyde-fixed and paraffin-embedded to fresh frozen material using, among others, tissue derived from our archives. Eisele et al. (2012) showed that although integrity measurements of RNA isolated from formaldehyde-fixed and paraffin-embedded material resulted in very low integrity numbers, amplicons with a length of 5150 bp were still detectable. Eisele et al. (2012) performed quantitative PCR-based transcript profiling analysing the expression of 84 extracellular matrix-related genes and identified a transcript loss of 47% in formaldehyde-fixed and paraffinembedded-derived samples in comparison with fresh frozen material. Of course, such false negative results can be expected in our study as well. We tried to minimize this problem accordingly by first of all using only tissue blocks that showed reasonable RNA preservation, as evidenced by strong in situ hybridization signals after a short time of development. Secondly, stringent RNA quality criteria were applied to ensure that only samples with sufficiently long RNA fragments were further processed. Thirdly, we used whole-genome microarrays from Agilent. As shown in Supplementary Table 4 , most of the probes of Agilent arrays were located within the last exon. Because the RNA fragments contained in our samples were amplified using poly(A) tail primers, the binding probability to the corresponding microarray probes was maximized. Fourthly, we focused on either highly significantly changed genes (P 5 0.01) or used restrictive cut-offs (log 2 foldchanges 44 or 5À 4.5). Additionally, we did not focus on single gene analysis, which would require much more stringent molecular and biochemical confirmation of the identified molecules. Instead, we used the microarray data for the identification of interconnected pathways within specific and extremely well characterized lesions. The involvement of these pathways in multiple sclerosis pathology, but not necessarily the involvement of single pathwayrevealing molecules, was then evaluated in immunohistochemical analyses using a much larger sample of cases and lesions. We want to point out that our microarray analyses also included a single case comparison (Case MS1 in comparison with all other cases). This was done, since this case showed an extreme degree of cortical inflammatory demyelinating activity, which is extremely rare in multiple sclerosis tissue available for pathological analysis (Kutzelnigg et al., 2005; Lucchinetti et al., 2011) and for this reason may be particularly informative with respect to the questions addressed in this study. Despite these limitations, a strong argument for the validity of our data is the fact that 480% of Figure 4 Neurons with intense cytoplasmic accumulation of oxidized phospholipids and DNA strand breaks are abundant in active cortical multiple sclerosis lesions. (A) Scatter plot displaying the percentage of neurons with intense, cytoplasmic E06 immunoreactivity in relation to the total number of counted cortical neurons. In active multiple sclerosis lesion areas, significantly more oxidatively damaged neurons are present in comparison with other inflammatory diseases (tuberculous meningitis/luetic meningitis/chronic purulent meningitis; P 5 0.05), neurodegenerative diseases (Alzheimer's disease; P 5 0.05), or control cases (P 5 0.001). The median value for each group is indicated by a grey bar. (B) Scatter plot of TUNEL-positive nuclei in the cortex of patients with multiple sclerosis in comparison with that of tuberculous meningitis, Alzheimer's disease and control subjects. Cells with DNA strand breaks are mainly present in the area of lesional activity in patients with multiple sclerosis (multiple sclerosis edge). NAGM = normal appearing grey matter; MS = multiple sclerosis; TB = tuberculous meningitis; LM = luetic meningitis; ME = chronic purulent meningitis; AD = Alzheimer's disease; CO = control; *P 5 0.05; ***P 5 0.001. . In contrast, macrophages with high immunoreactivity for inducible nitric oxide synthase are seen in more advanced lesions in the white matter of the same section (E). (F) The heat map presents colour-coded log 2 -transformed fold-changes of genes coding for NADPH oxidase components or nitric oxide synthase enzymes. For this analysis, the fulminate Case MS1 was compared with either tuberculous meningitis (TB1-3; left column) or controls (CO1-3; right column). The comparisons are in line with immunohistochemical studies suggesting oxidative damage to be driven by NOX1 and NOX2 components of NADPH oxidases and not by nitric oxide synthaseenzymes. The colour gradient was computed using 10th, 50th, and 90th percentiles. Green, black and red colours indicate downregulated, unchanged, and upregulated genes, respectively. The official gene symbol and RefSeq annotation number are shown for each gene. MS = multiple sclerosis; TB = tuberculous meningitis; CO = control; Scale bars: A = 200 mm; B and C = 50 mm; D and E = 100 mm. gene expression changes identified by our approach are related to interconnected molecular pathways, which in part have been suggested to operate in multiple sclerosis lesions before.
In conclusion, our study shows that focal plaque-like demyelination is a specific feature of cortical multiple sclerosis lesions and is associated with excessive oxidative damage, mainly affecting oligodendrocytes, neurons and their cell processes. The reason for excessive oxidative injury remains currently unresolved and may be related to the nature of the inflammatory process or to factors determining the susceptibility of neuronal tissue to inflammation in multiple sclerosis, such as brain ageing or accumulation of pre-existing damage. To answer this question, more extensive studies are necessary concentrating on highly active and inflammatory cortical multiple sclerosis lesions, which are very rare in archival autopsy material, but are sometimes seen in biopsies of multiple sclerosis brain tissue obtained during the early stages of the disease (Lucchinetti et al., 2011) .
